2
RESEARCH METHODOLOGY
31
5
MARKET OVERVIEW
Explore booming markets driven by aging populations and chronic disease trends, despite high therapy costs.
49
5.2.1.1
BOOMING GERIATRIC POPULATION
5.2.1.2
INCREASING CASES OF TRAUMATIC INJURIES
5.2.1.3
GROWING PREVALENCE OF CHRONIC DISEASES
5.2.1.4
RISING INCIDENCE OF BURN INJURIES
5.2.1.5
FAVORABLE GOVERNMENT AND INDUSTRY INITIATIVES AND REIMBURSEMENT POLICIES
5.2.2.1
HIGH COST OF NEGATIVE PRESSURE WOUND THERAPY DEVICES
5.2.2.2
RISKS ASSOCIATED WITH USE OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
5.2.3.1
GROWTH OPPORTUNITIES IN EMERGING ECONOMIES
5.2.3.2
INCREASING USE OF SIMPLIFIED SINGLE-USE DEVICES
5.2.4.1
AVAILABILITY OF ALTERNATIVE THERAPIES
5.2.4.2
LIMITED AWARENESS AMONG HEALTHCARE PROVIDERS
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4.1
AVERAGE SELLING PRICE TREND, BY PRODUCT
5.4.2
AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.4.3
AVERAGE SELLING PRICE TREND, BY REGION
5.6
SUPPLY CHAIN ANALYSIS
5.8
INVESTMENT AND FUNDING SCENARIO
5.9.1.1
VACUUM-ASSISTED CLOSURE (VAC) THERAPY
5.9.2
COMPLEMENTARY TECHNOLOGIES
5.9.2.1
TOPICAL OXYGEN THERAPY
5.9.3
ADJACENT TECHNOLOGIES
5.9.3.1
HYPERBARIC OXYGEN THERAPY
5.11.1
IMPORT DATA (HS CODE 901890)
5.11.2
EXPORT DATA (HS CODE 901890)
5.12
KEY CONFERENCES AND EVENTS, 2025–2026
5.13.1
CASE STUDY 1: COMPLEX WOUND HEALING WITH TOPICAL NEGATIVE PRESSURE WOUND THERAPY
5.13.2
CASE STUDY 2: NECROTIZING FASCIITIS MANAGED WITH NEGATIVE PRESSURE WOUND THERAPY FOR BETTER WOUND CLOSURE
5.13.3
CASE STUDY 3: TREATMENT OF HARD-TO-HEAL WOUNDS WITH PORTABLE NEGATIVE PRESSURE WOUND THERAPY
5.14
REGULATORY LANDSCAPE
5.14.1
REGULATORY ANALYSIS
5.14.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14.2.5
REST OF THE WORLD
5.15
PORTER’S FIVE FORCES ANALYSIS
5.15.1
BARGAINING POWER OF SUPPLIERS
5.15.2
BARGAINING POWER OF BUYERS
5.15.3
THREAT OF NEW ENTRANTS
5.15.4
THREAT OF SUBSTITUTES
5.15.5
INTENSITY OF COMPETITIVE RIVALRY
5.16
KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.17
IMPACT OF AI ON NEGATIVE PRESSURE WOUND THERAPY MARKET
5.17.2
MARKET POTENTIAL OF AI IN NEGATIVE PRESSURE WOUND THERAPY MARKET
5.17.4
KEY COMPANIES IMPLEMENTING AI
5.17.5
FUTURE OF AI IN NEGATIVE PRESSURE WOUND THERAPY MARKET
5.18
IMPACT OF US TARIFF REGULATION ON NEGATIVE PRESSURE WOUND THERAPY MARKET
5.18.3
PRICE IMPACT ANALYSIS
5.18.4
KEY IMPACT ON COUNTRY/REGION
5.18.5
IMPACT ON END-USE INDUSTRIES
6
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 19 Data Tables
86
6.2
CONVENTIONAL NPWT DEVICES
6.2.1
RISING FOCUS ON EFFECTIVE WOUND MANAGEMENT TO EXPEDITE GROWTH
6.3
SINGLE-USE NPWT DEVICES
6.3.1
INCREASING ADOPTION OF SINGLE-USE DEVICES IN HOME HEALTHCARE TO PROMOTE GROWTH
6.4
NPWT ACCESSORIES & CONSUMABLES
6.4.1
GROWING PREVALENCE OF CHRONIC WOUNDS TO DRIVE MARKET
7
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 28 Data Tables
97
7.2
BURNS AND SURGICAL & OPEN WOUNDS
7.2.1
HIGH INCIDENCE OF BURN INJURIES IN LOW AND MIDDLE-INCOME COUNTRIES TO AID GROWTH
7.3.1
INCREASING AGING POPULATION WORLDWIDE TO AUGMENT GROWTH
7.4.1
INCREASE PREVALENCE OF DIABETES TO STIMULATE GROWTH
7.5.1
RISING PREVALENCE OF OBESITY TO CONTRIBUTE TO GROWTH
7.6.1
GROWING INCIDENCE OF TRAUMATIC INJURIES TO BOOST MARKET
8
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 17 Data Tables
114
8.2.1
RISING NUMBER OF SURGERIES TO ACCELERATE GROWTH
8.3.1
INCREASING HEALTHCARE EXPENDITURE TO SPEED UP GROWTH
9
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 83 Data Tables.
124
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2.1
RISING REGULATORY APPROVALS AND FAVORABLE REIMBURSEMENT POLICIES TO STIMULATE GROWTH
9.2.3.1
INCREASING PREVALENCE OF DIABETES TO SUPPORT GROWTH
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2.1
INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES TO AID GROWTH
9.3.3.1
GROWING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS TO PROPEL MARKET
9.3.4.1
RISE IN HEALTHCARE BUDGET TO SPUR GROWTH
9.3.5.1
INCREASING NATIONAL HEALTHCARE FUNDING TO FAVOR GROWTH
9.3.6.1
INCREASING NUMBER OF SURGICAL PROCEDURES TO PROMOTE GROWTH
9.3.7.1
ESCALATING DIABETES ISSUE TO DRIVE MARKET
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2.1
INCREASING INCIDENCE OF DIABETIC FOOT ULCERS TO ENCOURAGE GROWTH
9.4.3.1
EVOLVING HEALTHCARE DELIVERY AND INFRASTRUCTURE LANDSCAPE TO FUEL MARKET
9.4.4.1
BOOMING MEDICAL TOURISM TO SPEED UP GROWTH
9.4.5.1
GROWING FOCUS ON DIABETES MANAGEMENT TO DRIVE MARKET
9.4.6.1
INCREASING AWARENESS AND FOCUS ON ADVANCED WOUND CARE THERAPIES TO FACILITATE GROWTH
9.4.7.1
INCREASING HEALTHCARE SPENDING TO SUSTAIN GROWTH
9.4.8
REST OF ASIA PACIFIC
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2.1
FREE HEALTHCARE SERVICES TO BOLSTER GROWTH
9.5.3.1
EXPANDING HOSPITAL INFRASTRUCTURE TO AID GROWTH
9.5.4
REST OF LATIN AMERICA
9.6.1
GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET
9.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10
COMPETITIVE LANDSCAPE
Discover strategic shifts shaping market dominance in negative pressure wound therapy.
173
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN NEGATIVE PRESSURE WOUND THERAPY MARKET
10.3
REVENUE ANALYSIS, 2022–2024
10.4
MARKET SHARE ANALYSIS, 2024
10.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1
COMPANY FOOTPRINT
10.5.5.2
REGION FOOTPRINT
10.5.5.3
PRODUCT TYPE FOOTPRINT
10.5.5.4
WOUND TYPE FOOTPRINT
10.5.5.5
END-USER FOOTPRINT
10.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1
PROGRESSIVE COMPANIES
10.6.2
RESPONSIVE COMPANIES
10.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
10.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.7
COMPANY VALUATION AND FINANCIAL METRICS
10.8
BRAND/PRODUCT COMPARISON
10.9
COMPETITIVE SCENARIO
10.9.1
PRODUCT LAUNCHES AND APPROVALS
10.9.4
OTHER DEVELOPMENTS
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
194
11.1.1.1
BUSINESS OVERVIEW
11.1.1.2
PRODUCTS OFFERED
11.1.1.3
RECENT DEVELOPMENTS
11.1.5
CONVATEC GROUP PLC
11.1.7
AVERY DENNISON CORPORATION
11.1.8
BENQ MATERIALS CORPORATION
11.1.9
ADVANCED OXYGEN THERAPY INC.
11.2.1
DOUBLE MEDICAL TECHNOLOGY INC.
11.2.3
DEROYAL INDUSTRIES, INC.
11.2.4
LOHMANN & RAUSCHER GMBH & CO. KG
11.2.6
GENADYNE BIOTECHNOLOGIES, INC.
11.2.7
DIRECT HEALTHCARE GROUP
11.2.12
GUANGZHOU RAINHOME PHARM & TECH CO., LTD.
11.2.14
DATT MEDIPRODUCTS PRIVATE LIMITED
11.2.15
KORAZON MEDICAL DEVICES PRIVATE LIMITED
11.2.16
TRIAGE MEDITECH PVT. LTD.
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3
CUSTOMIZATION OPTIONS
TABLE 1
NEGATIVE PRESSURE WOUND THERAPY MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2
NEGATIVE PRESSURE WOUND THERAPY MARKET: RISK ASSESSMENT
TABLE 3
POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023
TABLE 4
ROAD ACCIDENT DEMOGRAPHIC, 2022
TABLE 5
CHINA: STATES ON DISCHARGE OF PATIENTS WITH TYPE 2 DFU IN DIFFERENT AGE GROUPS, JANUARY 2017–DECEMBER 2023
TABLE 6
RISKS ASSOCIATED WITH NEGATIVE PRESSURE WOUND THERAPY DEVICES
TABLE 7
STRATEGIC DEVELOPMENTS IN ASIA PACIFIC, 2023–2024
TABLE 8
AVERAGE SELLING PRICING TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, 2023–2025
TABLE 9
AVERAGE SELLING PRICE TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, BY KEY PLAYER, 2023–2025
TABLE 10
AVERAGE SELLING PRICE TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, BY REGION, 2023–2025
TABLE 11
NEGATIVE PRESSURE WOUND THERAPY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 12
NEGATIVE PRESSURE WOUND THERAPY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024
TABLE 13
IMPORT DATA (HS CODE 901890), BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 14
EXPORT DATA (HS CODE 901890), BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 15
NEGATIVE PRESSURE WOUND THERAPY MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
TABLE 16
TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
TABLE 17
NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
NEGATIVE PRESSURE WOUND THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS (%)
TABLE 24
KEY BUYING CRITERIA FOR NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
TABLE 25
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 26
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 27
KEY COMPANIES OFFERING CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES
TABLE 28
CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 29
NORTH AMERICA: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 30
EUROPE: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31
ASIA PACIFIC: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 32
LATIN AMERICA: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33
KEY COMPANIES OFFERING SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES
TABLE 34
SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 35
NORTH AMERICA: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36
EUROPE: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37
ASIA PACIFIC: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38
LATIN AMERICA: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39
KEY COMPANIES OFFERING NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES
TABLE 40
NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 41
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42
EUROPE: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 46
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 52
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56
PREVALENCE OF DIABETES, 2024
TABLE 57
NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (THOUSANDS)
TABLE 58
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 59
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 64
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY REGION, 2023–2030 (USD MILLION)
TABLE 69
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 74
HOSPITALS PER CAPITA, BY COUNTRY, 2025
TABLE 75
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)
TABLE 76
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 80
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION, 2023–2030 (USD MILLION)
TABLE 81
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 82
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 86
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 88
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 91
NORTH AMERICA: KEY MACROECONOMIC INDICATORS
TABLE 92
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 94
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 95
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 96
US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 97
US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 98
US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 99
CANADA: ESTIMATED PREVALENCE OF DIABETES, 2023–2024
TABLE 100
CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 101
CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 102
CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 103
EUROPE: KEY MACROECONOMIC INDICATORS
TABLE 104
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 106
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 107
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 108
UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 109
UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 110
UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 111
GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 112
GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 113
GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 114
FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 115
FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 116
FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 117
ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 118
ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 119
ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 120
SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 121
SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 122
SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 123
RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 124
RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 125
RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 126
REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 127
REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 128
REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 129
ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
TABLE 130
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 131
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 132
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 133
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 134
CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 135
CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 136
CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 137
JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 138
JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 139
JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 140
INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 141
INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 142
INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 143
AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 144
AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 145
AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 146
SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 147
SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 148
SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 149
SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 150
SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 151
SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 152
REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 153
REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 154
REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 155
LATIN AMERICA: KEY MACROECONOMIC INDICATORS
TABLE 156
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 157
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 158
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 159
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 160
BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 161
BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 162
BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 163
MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 164
MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 165
MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 166
REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 167
REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 168
REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 169
MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS
TABLE 170
MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 171
MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
TABLE 172
MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 173
NEGATIVE PRESSURE WOUND THERAPY MARKET: OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2022–MARCH 2025
TABLE 174
NEGATIVE PRESSURE WOUND THERAPY MARKET: DEGREE OF COMPETITION
TABLE 175
NEGATIVE PRESSURE WOUND THERAPY MARKET: REGION FOOTPRINT
TABLE 176
NEGATIVE PRESSURE WOUND THERAPY MARKET: PRODUCT TYPE FOOTPRINT
TABLE 177
NEGATIVE PRESSURE WOUND THERAPY MARKET: WOUND TYPE FOOTPRINT
TABLE 178
NEGATIVE PRESSURE WOUND THERAPY MARKET: END-USER FOOTPRINT
TABLE 179
NEGATIVE PRESSURE WOUND THERAPY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 180
NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 181
NEGATIVE PRESSURE WOUND THERAPY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
TABLE 182
NEGATIVE PRESSURE WOUND THERAPY MARKET: DEALS, JANUARY 2022–MARCH 2025
TABLE 183
NEGATIVE PRESSURE WOUND THERAPY MARKET: EXPANSIONS, JANUARY 2022–MARCH 2025
TABLE 184
NEGATIVE PRESSURE WOUND THERAPY MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
TABLE 185
SOLVENTUM: COMPANY OVERVIEW
TABLE 186
SOLVENTUM: PRODUCTS OFFERED
TABLE 187
SOLVENTUM: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
TABLE 188
SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
TABLE 189
SMITH+NEPHEW: COMPANY OVERVIEW
TABLE 190
SMITH+NEPHEW: PRODUCTS OFFERED
TABLE 191
SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
TABLE 192
SMITH+NEPHEW: DEALS, JANUARY 2022–MARCH 2025
TABLE 193
SMITH+NEPHEW: EXPANSIONS, JANUARY 2022–MARCH 2025
TABLE 194
CARDINAL HEALTH: COMPANY OVERVIEW
TABLE 195
CARDINAL HEALTH: PRODUCTS OFFERED
TABLE 196
CARDINAL HEALTH: DEALS, JANUARY 2022–MARCH 2025
TABLE 197
CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–MARCH 2025
TABLE 198
MÖLNLYCKE AB: COMPANY OVERVIEW
TABLE 199
MÖLNLYCKE AB: PRODUCTS OFFERED
TABLE 200
MÖLNLYCKE AB: DEALS, JANUARY 2022–MARCH 2025
TABLE 201
CONVATEC GROUP PLC: COMPANY OVERVIEW
TABLE 202
CONVATEC GROUP PLC: PRODUCTS OFFERED
TABLE 203
CONVATEC GROUP PLC: DEALS, JANUARY 2022–MARCH 2025
TABLE 204
PAUL HARTMANN AG: COMPANY OVERVIEW
TABLE 205
PAUL HARTMANN AG: PRODUCTS OFFERED
TABLE 206
PAUL HARTMANN AG: DEALS, JANUARY 2022–MARCH 2025
TABLE 207
AVERY DENNISON CORPORATION: COMPANY OVERVIEW
TABLE 208
AVERY DENNISON CORPORATION: PRODUCTS OFFERED
TABLE 209
AVERY DENNISON CORPORATION: DEALS, JANUARY 2022–MARCH 2025
TABLE 210
AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2022–MARCH 2025
TABLE 211
BENQ MATERIALS CORPORATION: COMPANY OVERVIEW
TABLE 212
BENQ MATERIALS CORPORATION: PRODUCTS OFFERED
TABLE 213
BENQ MATERIALS CORPORATION: DEALS, JANUARY 2022–MARCH 2025
TABLE 214
BENQ MATERIALS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
TABLE 215
ADVANCED OXYGEN THERAPY INC.: COMPANY OVERVIEW
TABLE 216
ADVANCED OXYGEN THERAPY INC.: PRODUCTS OFFERED
TABLE 217
ADVANCED OXYGEN THERAPY INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
TABLE 218
DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW
TABLE 219
CARILEX MEDICAL: COMPANY OVERVIEW
TABLE 220
DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW
TABLE 221
LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW
TABLE 222
MEDAXIS LLC: COMPANY OVERVIEW
TABLE 223
GENADYNE BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 224
DIRECT HEALTHCARE GROUP: COMPANY OVERVIEW
TABLE 225
ALLEVA MEDICAL: COMPANY OVERVIEW
TABLE 226
CORK MEDICAL, LLC: COMPANY OVERVIEW
TABLE 227
PENSAR MEDICAL: COMPANY OVERVIEW
TABLE 228
HAROMED: COMPANY OVERVIEW
TABLE 229
GUANGZHOU RAINHOME PHARM & TECH CO., LTD.: COMPANY OVERVIEW
TABLE 230
GUARD MEDICAL: COMPANY OVERVIEW
TABLE 231
DATT MEDIPRODUCTS PRIVATE LIMITED: COMPANY OVERVIEW
TABLE 232
KORAZON MEDICAL DEVICES PRIVATE LIMITED: COMPANY OVERVIEW
TABLE 233
TRIAGE MEDITECH PVT. LTD.: COMPANY OVERVIEW
FIGURE 1
NEGATIVE PRESSURE WOUND THERAPY MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 2
NEGATIVE PRESSURE WOUND THERAPY MARKET: RESEARCH DESIGN
FIGURE 3
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4
BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 5
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 6
NEGATIVE PRESSURE WOUND THERAPY MARKET: TOP-DOWN APPROACH
FIGURE 7
DATA TRIANGULATION METHODOLOGY
FIGURE 8
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 9
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 10
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 11
GEOGRAPHICAL SNAPSHOT OF NEGATIVE PRESSURE WOUND THERAPY MARKET, 2025–2030
FIGURE 12
INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET
FIGURE 13
HOSPITALS SEGMENT AND CHINA LED ASIA PACIFIC MARKET IN 2024
FIGURE 14
CHINA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030
FIGURE 15
ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 16
NEGATIVE PRESSURE WOUND THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17
NEGATIVE PRESSURE WOUND THERAPY MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 18
NEGATIVE PRESSURE WOUND THERAPY MARKET: VALUE CHAIN ANALYSIS
FIGURE 19
NEGATIVE PRESSURE WOUND THERAPY MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 20
NEGATIVE PRESSURE WOUND THERAPY MARKET: ECOSYSTEM ANALYSIS
FIGURE 21
NEGATIVE PRESSURE WOUND THERAPY MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2025
FIGURE 22
NEGATIVE PRESSURE WOUND THERAPY MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024
FIGURE 23
NEGATIVE PRESSURE WOUND THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 24
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
FIGURE 25
KEY BUYING CRITERIA FOR NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
FIGURE 27
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET SNAPSHOT
FIGURE 28
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET SNAPSHOT
FIGURE 29
NEGATIVE PRESSURE WOUND THERAPY MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024
FIGURE 30
NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 31
RANKING OF KEY PLAYERS IN NEGATIVE PRESSURE WOUND THERAPY MARKET, 2024
FIGURE 32
NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 33
NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY FOOTPRINT
FIGURE 34
NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 35
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 36
EV/EBITDA OF KEY VENDORS
FIGURE 37
NEGATIVE PRESSURE WOUND THERAPY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 38
SOLVENTUM: COMPANY SNAPSHOT (2024)
FIGURE 39
SMITH+NEPHEW: COMPANY SNAPSHOT (2024)
FIGURE 40
CARDINAL HEALTH: COMPANY SNAPSHOT (2024)
FIGURE 41
MÖLNLYCKE AB: COMPANY SNAPSHOT (2024)
FIGURE 42
CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024)
FIGURE 43
PAUL HARTMANN AG: COMPANY SNAPSHOT (2024)
FIGURE 44
AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 45
BENQ MATERIALS CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 46
ADVANCED OXYGEN THERAPY INC.: COMPANY SNAPSHOT (2024)
Growth opportunities and latent adjacency in Negative Pressure Wound Therapy Market